Peter De Jianne at Memorial Sloan Kettering Cancer center (MSK) playing with some of the patients.
100% of the net proceeds will be donated directly to pediatric cancer research at MSK.
More about Msk
- MSK’s Department of Pediatrics treats more children with cancer than any other institution in the U.S.
- Over 100 clinical trials providing cutting edge care.
- 90% of therapies provided outpatient.
- One of only 2 pediatric intensive care units dedicated exclusively to children with cancer.
Fast Facts about Pediatric Cancer
- An estimated 16,000 children in the U.S. were diagnosed with cancer in 2016.
Cancer is the leading cause of death by disease in children in the United States.
Today 81 percent of children survive pediatric cancers five years or more today vs 58 percent in the mid-1970s.
Giving to Precision Medicine at MSK
Only 4% of the National Cancer Institute’s research budget is dedicated to pediatric cancers. That’s
where MSK’s philanthropic community comes in. Donations made to MSK’s Department of Pediatrics
allow our doctors and scientists to find new and better treatments for kids with cancer.
MSK Pediatrics is home to a game-changing precision oncology program. They treat more children with
cancer than any other hospital in the United States, and their researchers are now offering to sequence the
genomes of every one of them.
More precise treatments can then be created for children based on their DNA, which promise to be more
effective and have fewer side effects — and that’s the goal! Your support of the precision oncology program
will give doctors the ability to better understand and target pediatric cancers on a DNA level.
Scientists are getting more precise when they diagnose and treat cancer! By looking at the DNA of tumors and
comparing it to kids’ healthy cells, they try to find the genetic mutations that caused the cancer in the first place.
By targeting these mutations with the right drugs, doctors can fight cancer more accurately— and avoid harming
healthy cells. This means kids will experience fewer side effects than they would from chemotherapy.